Teva Pharmaceuticals @TevaUSA
At the @DefeatNCD #WHS2020 panel session on Access to Sustainable NCD Treatment & Care, Teva’s Amalia Adler-Waxman shared how partnerships can support access to NCD medicines for patients in low- and middle-income countries. @WorldHealthSmt #defeatNCDs — PolitiTweet.org
The Defeat-NCD Partnership @DefeatNCD
1/2 Thank you to all the panelists and speakers of our high-level session @WorldHealthSmt You can watch the full… https://t.co/TW1cRWaEtv